Although Dolutegravir has proved safe in clinical trials, some observational studies have reported high rates of discontinuations due to adverse events mostly affecting the CNS. The aim of the present study was to evaluate the safety of DTG in a real life setting.
Dolutegravir safety in a real-life setting: results from the SCOLTA cohort.
G. Pellicanò;
2019-01-01
Abstract
Although Dolutegravir has proved safe in clinical trials, some observational studies have reported high rates of discontinuations due to adverse events mostly affecting the CNS. The aim of the present study was to evaluate the safety of DTG in a real life setting.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
